AN2 Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
23.33
|
|
Average Rating
|
5.00
|
|
# Strong Buys
|
4
|
|
# Buys
|
0
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-03-31
|
-0.69
|
0.00
|
0.69
|
100.00%
|
|
2022-12-31
|
-0.64
|
0.00
|
0.64
|
100.00%
|
|
2022-09-30
|
-0.59
|
-0.59
|
0.00
|
0.00%
|
|
2022-06-30
|
-0.46
|
-0.53
|
-0.07
|
-15.22%
|
|
2022-03-31
|
-0.52
|
-2.98
|
-2.46
|
-473.08%
|
|
2021-12-31
|
0.00
|
0.00
|
0.00
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-4.10
|
|
2021-12-31
|
0.00
|